[1]
|
Katalinic, A. and Rawal, R. (2008) Epidemiology decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Research Treatment, 107, 427-430. doi:10.1007/s10549-007-9566-z
|
[2]
|
Leung, T.K., Huang, P.J., Chen, C.S., Lin, Y.H., Wu, C.H. and Lee, C.M. (2010) Is breast MRI screening more effective than digital mammography in Asian women? Journal of Experimental & Clinical Medicine, 2, 245-250.
doi:10.1016/S1878-3317(10)60038-1
|
[3]
|
Erguvan-Dogan, B., Whitman, G.J., Kushwaha, A.C., Phelps, M.J. and Dempsey, P.J. (2006) BI-RADS-MRI: A primer. American Journal of Roentgenology, 187, W152-W160. doi:10.2214/AJR.05.0572
|
[4]
|
Stephens, T.W. (1998) Illustrated breast imaging reporting and data system (BI-RADS). 3rd Edition, American College of Radiology, Reston.
|
[5]
|
Liberman, L. and Menell, J.H. (2002) Breast imaging reporting and data system (BI-RADS). Radiologic Clinics of North America, 40, 409-430.
doi:10.1016/S0033-8389(01)00017-3
|
[6]
|
Leung, T.K., Chu, J.S., Huang, P.J., Lee, C.M., Lin, Y.H., Chen, C.S., Tai, C.J. and Wu, C.H. (2010) Breast MRI for monitoring images of an “adenomyoepithelioma with malignant features”, before, during, and after chemotherapy. Breast Journal, 16, 652-653.
doi:10.1111/j.1524-4741.2010.01009.x
|
[7]
|
Leung, T.K., Huang, P.J., Lee, C.M., Chen, C.S., Wu, C.H. and Chao, J.S. (2010) Can breast magnetic resonance imaging demonstrate characteristic findings of preoperative ductal carcinoma in situ in Taiwanese women? Asian Journal of Surgery, 33, 143-149.
doi:10.1016/S1015-9584(10)60024-3
|
[8]
|
Leung, T.K., Huang, P.J., Lee, C.M. and Chen, C.S. (2012) Silicone breast implant with intracapsular rupture coexisting with locally advanced carcinoma. Breast Journal, 18, 76-77. doi:10.1111/j.1524-4741.2011.01187.x
|
[9]
|
Key, T.J., Chen, J., Wang, D.Y., Pike, M.C. and Boreham, J. (1990) Sex hormones in women in rural China and in Britain. British Journal of Cancer, 62, 631-636.
doi:10.1038/bjc.1990.344
|
[10]
|
Clemons, M. and Goss, P. (2001) Estrogen and the risk of breast cancer. New England Journal of Medicine, 344, 276-285. doi:10.1056/NEJM200101253440407
|
[11]
|
Tsai, A.C., Liou, J.C., Chang, M.C. and Chuang, Y.L. (2007) Influence of diet and physical activity on aging-associated body fatness and anthropometric changes in older Taiwanese. Nutrition Research, 27, 245-251.
doi:10.1016/j.nutres.2007.03.002
|
[12]
|
Hsieh, S.C., Lai, J.N., Lee, C.F., Hu, F.C., Tseng, W.L. and Wang, J.D. (2008) The prescribing of Chinese herbal products in Taiwan: A cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiological Drug Safety, 17, 609-619.
doi:10.1002/pds.1611
|
[13]
|
Dupont, W.D. and Page, D.L. (1985) Risk factors for breast cancer in women with proliferative breast disease. New England Journal of Medicine, 312, 146-151.
doi:10.1056/NEJM198501173120303
|
[14]
|
Hsieh, C.Y., Santell, R.C., Haslam, S.Z. and Helferich, W.G. (1998) Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF7) cells in vitro and in vivo. Cancer Research, 58, 3833-3838.
|
[15]
|
Zava, D.T. and Duwe, G. (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutrition Cancer, 27, 31-40. doi:10.1080/01635589709514498
|
[16]
|
Wang, T.T., Sathyamoorthy, N. and Phang, J.M. (1996) Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 17, 271-275.
doi:10.1093/carcin/17.2.271
|
[17]
|
Yager, J.D. and Davidson, N.E. (2006) Estrogen carcinogenesis in breast cancer. New England Journal of Medicine, 354, 270-282. doi:10.1056/NEJMra050776
|
[18]
|
Peeters, P.H.M., Keinan-Boker, L., van der Schouw, Y.T. and Grobbee, D.E. (2003) Phytoestrogens and breast cancer risk: Review of the epidemiological evidence. Breast Cancer Research Treatment, 77, 171-183.
doi:10.1023/A:1021381101632
|
[19]
|
Keinan-Boker, L., van der Schouw, Y.T., Grobbee, D.E. and Peeters, P.H.M. (2004) Dietary phytoestrogens and breast cancer risk. American Journal of Clinical Nutrition, 79, 282-288.
|
[20]
|
Duffy, C., Perez, K. and Partridge, A. (2007) Implications of phytoestrogen intake for breast cancer. Ca-A Cancer Journal for Clinicians, 57, 260-277.
doi:10.3322/CA.57.5.260
|
[21]
|
Bouker, K.B. and Hilakivi-Clarke, L. (2000) Genistein: Does it prevent or promote breast cancer? Environmental Health Perspectives, 108.
|
[22]
|
Mayo, J.L. (1997) A Natural approach to menopause. Clinical Nutrition Insights, 5, 1-8.
|
[23]
|
Huang, K.C. (1993) The pharmacology of Chinese herbs. CRC Press, Boca Raton.
|
[24]
|
Yapa, S.P., Shena, P., Lia, J., Leeb, L.S. and Yonga, E.L. (2007) Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb, Epimedium. Journal of Ethnopharmacology, 113, 218-224. doi:10.1016/j.jep.2007.05.029
|
[25]
|
Wang, Z.Q. and Lou, Y.J. (2004) Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells. European Journal of Pharmacology, 504, 147-153.
doi:10.1016/j.ejphar.2004.10.002
|